Background: Pancreatic fluid collections (PFCs) can develop as a complication in 6-20% of acute pancreatitis cases. According to the revised Atlanta Classification, PFCs warranting endoscopic drainage are categorized as either a pancreatic pseudocyst (PP) or walled-off necrosis (WON). Endoscopic-ultrasound (EUS)-guided drainage of PFCs has become the preferred modality of initial intervention but there remains debate as to the optimal type of stent. A recent trend towards the use of lumenapposing metal stents (LAMS) has emerged. Aims: To evaluate the performance characteristics of a LAMS in the EUS-guided endoscopic management of PFCs based on our institutional protocol (CT scan 1 week after placement to assess for resolution and need for necrosectomy followed by stent removal within in 3 weeks of placement). Methods: A prospective registry of all patients that underwent PFC drainage with a LAMS. The primary outcome was stent functionality (absence of stent-related reintervention during period of stent indwell). Secondary outcomes were clinical success (sustained resolution at 3 months after LAMS removal), technical success, procedure time, total number of endoscopic procedures with or without necrosectomy, stent indwell time and adverse events (buried stent, migration, bleeding, perforation and 30-day mortality). Results: Twenty-seven patients (16 males, with median age 47 years [range 9-85]) underwent placement of LAMS for 29 PFCs (median size 11 cm [range 6-22 cm]). There were 13/29 (45%) PP and 16/29 (55%) WON. Technical success and stent functionality was 100%, respectively. The median procedure time was 13 min . A total of 6/29 (21%) PFCs (1 PP, 5 WON) required repeat endoscopy during stent indwell. No intervention was undertaken in the 1 PP. In the 5 WONs, 4 underwent necrosectomy (3 necrosectomy sessions in 1, 2 sessions in 1 and 1 session in 2) and 1 required no intervention. The median stent indwell time was 20 days (IQR 13-28 days). Clinical success was seen in 24/29 (83%) PFCs. The remaining 5 patients had successful resolution of their PFC but 3 underwent surgery (1 had unrelenting abdominal sepsis, 1 had PFC extending into both para-colic gutters
and 1 had the gastro-duodenal artery traversing the PFC contraindicating necrosectomy) and 2 patients died from underlying malignant disease. There were no adverse events although 2 patients died within 30 days not related to the LAMS (discussed above). Conclusions: Our institutional protocol of PFC demonstrated excellent performance characteristics of LAMS. LAMS may be the preferred modality for endoscopic management of PFCs.
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